Skip to the answer

Methylergonovine Uses, Dosage, Side Effects and Interactions

Brand names
Methergine

Methergine was the first methylergonovine product the FDA approved, in 1946. An FDA-approved generic with the same active ingredient is listed.

Methylergometrine

Methylergometrine is a brand name for methylergonovine. It is not in the FDA’s directory today; generic methylergonovine is.

Methylergonovine is a uterine-contracting medicine used after childbirth to manage uterine atony, bleeding (hemorrhage) and subinvolution of the uterus, and to control uterine bleeding during labor. It comes as a tablet and as an injection.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About MethylergonovineType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Methylergonovine in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Methylergonovine (Methergine) is an ergot medicine that makes the uterus contract firmly after childbirth to cut bleeding and help it shrink back. It is an older standby, on the U.S. market since about 1946 with FDA-approved generics listed, and is most often a second option after oxytocin, the standard first choice. A short course is generally well tolerated, though strong cramping (like heavy afterpains) and nausea are common. The thing to watch is a sudden rise in blood pressure, which is why it is not for anyone with high blood pressure, toxemia (pregnancy-related high blood pressure) or a current pregnancy, and why a severe headache or chest pain needs help right away.

Key Takeaways From the HelloPharmacist Team

  • Take the tablets 3 or 4 times a day for no more than one week after delivery; any injection is given by your care team.
  • Store the tablets well apart from your baby’s medicines, and get emergency help if a newborn is ever given any by mistake.
  • Avoid clarithromycin, ritonavir and antifungals like ketoconazole or itraconazole while taking it, and mention it whenever a new medicine is prescribed.
  • Pause breastfeeding during the tablet course, discard milk made meanwhile, and wait at least 12 hours after the last dose before nursing.

How we write and review this content: our editorial policy

Methylergonovine by the Numbers

Strengths
2
across 2 forms
Makers and packagers
13
Earliest FDA record
1946
Rank by Medicaid prescriptions
#1,058 of 1,682 drugs
More prescriptions than 37% of the 1,682 drugs we measure
5,549 prescriptions, Q1–Q4 2025

Patient Information Guide for Methylergonovine

What It’s Used For

Methylergonovine is used after childbirth and during labor. Uses by product:

  • Methergine tablets and Methylergonovine Maleate tablets: routine management of uterine atony, hemorrhage and subinvolution of the uterus after delivery of the placenta.
  • Methylergonovine Maleate injection: the same uses after delivery of the placenta.
  • Methylergonovine Maleate injection and tablets: control of uterine hemorrhage in the second stage of labor after delivery of the anterior shoulder, as listed in their labels.

How It Works

Methylergonovine acts directly on the smooth muscle of the uterus. It increases the tone, rate and strength of its rhythmic contractions. This produces a rapid, sustained tightening of the uterus. That shortens the third stage of labor and reduces blood loss.

Drug Class

Drug Class

  • Ergot Derivative
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)
  • Ergot Derivative

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)

None listed for Methylergonovine in the FDA’s index.

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)

None listed for Methylergonovine in the FDA’s index.

From our Patient Information GuideMethylergonovine acts directly on the smooth muscle of the uterus. It increases the tone, rate and strength of its rhythmic contractions. This produces a rapid, sustained tightening of the uterus. Read How Methylergonovine Works

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)
  • Ergolines

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Ergot alkaloids

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

The injection and tablets are used differently.

  • Injection: given into a muscle or slowly into a vein by a healthcare professional. It may be repeated every 2 to 4 hours if needed. Vein injection is not routine and is given over at least 60 seconds.
  • Tablets: taken by mouth about 3 or 4 times a day after delivery, for up to 1 week.

Follow your prescriber's directions. Ask your pharmacist or prescriber what to do about a missed dose.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Methylergonovine Taken by Mouth

Bleeding and uterus problems after childbirth
For women after delivery
Usual dose 1 tablet (0.2 mg each) 3 or 4 times a day
  • One tablet (0.2 mg each), 0.2 mg, orally 3 or 4 times daily in the puerperium for a maximum of 1 week

Also 1 week

See the Full Dosing Instructions on DailyMed →

Methylergonovine Injection

Bleeding and uterus problems after childbirth
Women during or after delivery · Injection into a muscle Usual dose 1 mL (0.2 mg) into a muscle
  • 1 mL, 0.2 mg, intramuscularly after delivery of the anterior shoulder, after delivery of the placenta, or during the puerperium
  • May be repeated as required, at intervals of 2 to 4 hours
Women during or after delivery · Injection into a vein Usual dose 1 mL (0.2 mg) into a vein
  • 1 mL, 0.2 mg, intravenously, administered slowly over a period of no less than 60 seconds

See the Full Dosing Instructions on DailyMed →

Side Effects

The most common side effects are:

Common side effects

  • High blood pressure, sometimes with headache or seizure
  • Low blood pressure
  • Abdominal pain (from the uterus contracting)
  • Nausea
  • Vomiting
  • Abdominal pain from uterine contractions

When to get medical help

  • Chest pain, or signs of a heart attack, which have been reported rarely
  • Severe headache, seizure, or signs of stroke, which can come with a sudden rise in blood pressure
  • Numbness, tingling or coldness in the hands or feet
  • Shortness of breath, a very slow or fast heartbeat, or palpitations
  • Signs of a serious allergic reaction, which have been reported rarely
  • Any exposure of a newborn to this medicine (breathing trouble, seizures, bluish skin, low urine output): get emergency help

Warnings and Precautions

  • Vein injection: it should not be given routinely into a vein because of the risk of sudden high blood pressure and stroke-type events.
  • Heart disease: people with coronary artery disease or its risk factors may be more likely to have a heart attack from blood vessel spasm.
  • Medication errors: newborns have been given the tablets by mistake, with breathing problems, seizures and bluish skin. Store it separately from newborn medicines.
  • Breastfeeding: do not breastfeed during tablet treatment. Wait at least 12 hours after the last dose.
  • Liver or kidney problems: use caution.

Interactions

Several medicines and substances can change how methylergonovine works or increase its risks.

  • Strong and moderate CYP 3A4 inhibitors (clarithromycin, ritonavir, ketoconazole, itraconazole, fluconazole, fluvoxamine, nefazodone, grapefruit juice): should not be combined, due to the risk of blood vessel spasm with similar ergot medicines.
  • Weak CYP 3A4 inhibitors (cilostazol, ranitidine): use with caution.
  • Rifampin and nevirapine: likely to weaken its effect.
  • Beta-blockers: may increase blood vessel narrowing.
  • Halothane and methoxyflurane: may reduce its effect on the uterus.
  • Nitroglycerin and other angina medicines: their effect may be reduced.
  • Other vasoconstrictors, ergot alkaloids, prostaglandins: use with caution.

Interactions Listed in the FDA-Approved Label

From the Methylergonovine prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • Strong and moderate CYP 3A4 inhibitors For example: saquinavir, grapefruit juice, nefazodone, macrolide antibiotics such as troleandomycin and clarithromycin, ritonavir, indinavir, nelfinavir, ketoconazole, itraconazole, voriconazole, fluconazole, fluvoxamine, clotrimazole
    What happensSerious events with similar ergot drugs and potent CYP 3A4 inhibitors have caused vasospasm leading to cerebral ischemia and/or ischemia of the extremities.
    What to doShould not be co-administered with methylergonovine.
  • Weak CYP 3A4 inhibitors For example: chlorzoxazone, cilostazol, ranitidine
    What happensThese may interact with methylergonovine through CYP 3A4.
    What to doAdminister with caution.
  • Strong CYP3A4 inducers For example: nevirapine, rifampin
    What happensLikely to decrease the pharmacological action of methylergonovine.
  • Beta-blockers
    What happensMay enhance the vasoconstrictive action of ergot alkaloids.
    What to doUse caution when used together.
  • Anesthetics (halothane, methoxyflurane)
    What happensMay reduce the oxytocic potency of methylergonovine.
  • Glyceryl trinitrate and other antianginal drugs
    What happensMethylergonovine causes vasoconstriction and can be expected to reduce the effect of these drugs.
  • Other vasoconstrictors, ergot alkaloids, or prostaglandins
    What happensConcurrent use may interact with methylergonovine.
    What to doUse caution when used together.
Read the label’s full interactions text

Drug Interactions CYP 3A4 inhibitors (e.g., Macrolide Antibiotics and Protease Inhibitors) There have been rare reports of serious adverse events in connection with the coadministration of certain ergot alkaloid drugs (e.g., dihydroergotamine and ergotamine) and potent CYP 3A4 inhibitors, resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities. Although there have been no reports of such interactions with methylergonovine alone, potent CYP 3A4 inhibitors should not be coadministered with methylergonovine. Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole). Less potent CYP 3A4 inhibitors should be administered with caution. Less potent inhibitors include saquinavir, nefazodone, fluconazole, grapefruit juice, fluoxetine, fluvoxamine, zileuton, and clotrimazole. These lists are not exhaustive, and the prescriber should consider the effects on CYP 3A4 of other agents being considered for concomitant use with methylergonovine. CYP3A4 inducers Drugs (e.g. nevirapine, rifampicin) that are strong inducers of CYP3A4 are likely to decrease the pharmacological action of methylergonovine maleate tablets, USP. Beta-blockers Caution should be exercised when methylergonovine maleate tablets, USP are used concurrently with beta-blockers. Concomitant administration with beta-blockers may enhance the vasoconstrictive action of ergot alkaloids. Anesthetics Anesthetics like halothan and methoxyfluran may reduce the oxytocic potency of methylergonovine maleate tablets, USP. Glyceryl trinitrate and other antianginal drugs Methylergonovine maleate produces vasoconstriction and can be expected to reduce the effect of glyceryl trinitrate and other antianginal drugs.

Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Do not use it with high blood pressure, toxemia, pregnancy or a known allergy to it.
  • Tell your doctor about coronary artery disease, smoking, obesity, diabetes or high cholesterol.
  • Use caution with liver or kidney problems.
  • Do not breastfeed during tablet treatment. Discard milk made during that time and wait at least 12 hours after the last dose.

Overdose

Too much can cause nausea, vomiting, low urine output, abdominal pain, numbness and tingling in the hands and feet, and high blood pressure. In severe cases it can be followed by low blood pressure, slowed breathing, low body temperature, seizures and coma. Treatment is symptom-based, so get emergency help right away. Newborns who were given it by mistake needed urgent care.

Half-Life and How Your Body Processes It

After a vein injection, it moves quickly from the blood into body tissues. About 60% of an oral dose is absorbed. This is probably lower because of first-pass metabolism in the liver. Muscle injection absorption is higher (78% during delivery), and about 25% greater than the tablet. Tablets reach peak blood levels in about 1 hour, though absorption can be slower in postpartum women (about 3 hours). The average half-life after a muscle injection is about 3.4 hours (range 1.5 to 12.7 hours).

Storage

STORE AND DISPENSE Tablets: Store below 25°C (77°F); in a tight, light-resistant container.

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Supplements and Herbs That Interact With Methylergonovine

From the licensed clinical database we use, rolled up per supplement, most serious first.

20 supplements and herbal products have documented interactions with Methylergonovine in the licensed clinical database we use.

Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.

  • 1Major
  • 10Moderate
  • 9Minor

See the other 12

Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

Methylergonovine: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Methylergonovine — the kind of thing our pharmacy team would talk through with you at the counter.

What is methylergonovine used for?

It helps your uterus contract after delivery. That helps manage a relaxed uterus, heavy bleeding, and a uterus that is slow to shrink back. It is also used to control uterine bleeding during labor.

How long does methylergonovine take to work?

It works fast. By vein it acts immediately. A muscle injection takes about 2 to 5 minutes, and a tablet takes about 5 to 10 minutes.

How long do I take the tablets?

The tablets are taken by mouth about 3 or 4 times a day after delivery, for no more than 1 week. Follow the schedule your prescriber gives you. If you miss a dose, ask your pharmacist or prescriber what to do.

Can I breastfeed while taking methylergonovine?

Not while you are taking the tablets. The medicine may affect your baby and may reduce your milk supply. Discard milk made during treatment and wait at least 12 hours after your last dose before you start or restart breastfeeding.

What side effects should I expect, and which are urgent?

You may have belly cramping from the uterus tightening, nausea or vomiting. Blood pressure changes can also occur. Call for help right away if you have chest pain, a severe headache, a seizure, trouble breathing or signs of an allergic reaction.

Are there medicines or foods I should avoid with methylergonovine?

Yes. Strong and moderate CYP 3A4 inhibitors should not be combined with it. Examples are clarithromycin, ritonavir, ketoconazole and grapefruit juice. Tell us about everything you take, including beta-blockers and angina medicines.

Is methylergonovine available over the counter?

No. Methylergonovine is a prescription medicine: every methylergonovine product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was methylergonovine first available?

The earliest FDA record we hold for methylergonovine is from 1946: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when methylergonovine was first used.

Who makes methylergonovine?

13 companies currently list methylergonovine products in the FDA's NDC Directory, including Bryant Ranch Prepack, HF Acquisition Co LLC, DBA HealthFirst, American Health Packaging. That count includes repackagers and distributors as well as manufacturers (companies that sell only the raw ingredient are not counted), so fewer companies actually make it; the label on your bottle names the one that supplied yours.

What is the brand name of methylergonovine?

Methylergonovine is the generic name. Its brand names are Methergine and Methylergometrine. Generic versions are listed under the name methylergonovine.

What is the generic name of Methergine?

The generic name of Methergine is methylergonovine. A generic name is the name of the active ingredient, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is methylergonovine?

Methylergonovine belongs to the drug class Ergot Derivative, its established pharmacologic class on the FDA label.

Is there a generic version of methylergonovine?

Yes. FDA-approved generic versions of methylergonovine are listed in the FDA's National Drug Code Directory. A listing does not prove that every pharmacy stocks one, so your pharmacy can tell you which version it carries.

What strengths does methylergonovine come in?

Methylergonovine is listed in the FDA's National Drug Code Directory in these forms and strengths. Tablet (by mouth): 0.2 mg. Injection (into a muscle, into a vein): 0.2 mg/mL. A listing does not mean every pharmacy stocks every strength.

How much does methylergonovine cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, pharmacies paid a national average of $5.70 per 0.2 mg generic tablet as of November 18, 2026 (CMS's NADAC survey). That is the pharmacy's own cost for the medicine, not the price at the counter. No national price was found for methylergonovine injections. The pharmacy prices section of this page lists every strength priced.

Is there a methylergonovine shortage?

No. Methylergonovine is not on the FDA's drug shortage list as of Nov 22, 2026. A single pharmacy can still run short for a while without a national shortage, and your pharmacist can tell you what they are seeing.

Where can I read the methylergonovine prescribing information (package insert)?

The full FDA-approved prescribing information for methylergonovine, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Granules Pharmaceuticals Inc.'s, revised Oct 8, 2026, and links to it on DailyMed.

Can you crush methylergonovine?

One form of methylergonovine is on our Do Not Crush list of tablets and capsules that should not be crushed or chewed: methylergonovine (tablet). Crushing or splitting a hazardous drug can expose whoever handles it. A form that is not on the list may still come with its own instructions, so check the label and ask your pharmacist before you crush, split or open any medicine. Each listed form’s reason and instructions are on our Do Not Crush list.

Is methylergonovine gluten free?

No methylergonovine label we read lists an ingredient made from wheat, barley or rye, the grains that carry gluten. We read the FDA labels of 15 methylergonovine products from 13 companies. Of those, 1 names a starch, dextrin or maltodextrin without saying where it comes from, so for that one the answer is "source unclear", not "no". A label lists ingredients; it is not a gluten test, so we cannot promise that any product has no gluten. If you have celiac disease, ask the company for a written gluten statement. Our Inactive Ingredient Checker shows each company's methylergonovine by strength and NDC, and whether its label lists a gluten source, lactose, dyes or any other inactive ingredient. See methylergonovine inactive ingredients by company

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Methylergonovine

Skip the scrolling. Ask in your own words and get an answer from Methylergonovine’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Methylergonovine’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Methylergonovine on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, as soon as they can.
Detailed Data & References for Methylergonovine Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Methylergonovine Forms and Strengths (How It Comes)

Methylergonovine comes in 2 dose forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Methylergonovine inactive ingredients by manufacturer.

Tablet

By mouth
Brands Methergine (the first brand, 1946)
How this form is used
What it may be used for
  • Methergine tablets are used after delivery of the placenta to manage uterine atony, hemorrhage and subinvolution of the uterus.
  • Methylergonovine Maleate tablets are used to control uterine hemorrhage in the second stage of labor after delivery of the anterior shoulder.
Important instructions
  • Methergine tablets are taken by mouth 3 or 4 times daily after delivery, for a maximum of 1 week.
  • Methylergonovine Maleate tablets are taken by mouth 3 or 4 times daily in the puerperium, for a maximum of 1 week.
  • Do not breastfeed during treatment with Methylergonovine Maleate tablets, and wait at least 12 hours after the last dose.
Available strengths 1 strength
8 FDA-listed product records ⓘ

Injection

Into a muscle · Into a vein
How this form is used
What it may be used for
  • Methylergonovine Maleate injection is used after delivery of the placenta to manage uterine atony, hemorrhage and subinvolution of the uterus.
  • Methylergonovine Maleate injection is used to control uterine hemorrhage in the second stage of labor after delivery of the anterior shoulder.
Important instructions
  • Methylergonovine Maleate injection can be given into a muscle, and may be repeated at intervals of 2 to 4 hours if required.
  • Methylergonovine Maleate injection given into a vein should be given slowly over no less than 60 seconds, and is not routinely given this way.
  • Methylergonovine Maleate injection should be checked visually for particles and discoloration before use.
Available strengths 1 strength
7 FDA-listed product records ⓘ

Methylergonovine on the U.S. Market: Products, Makers and Brands

How Methylergonovine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

13 companies list 15 Methylergonovine product records with the FDA, mostly as tablet, injection; the earliest marketing or approval year on record is 1946. The one brand name in the directory today is Methergine; the rest are generics.

2
Dose forms ⓘ
13
Labelers (makers, repackagers, distributors)
2
Brand names ⓘ
15
FDA-listed product records ⓘ
1946
Earliest FDA record ⓘ

FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

Bryant Ranch Prepack13%
HF Acquisition Co LLC, DBA HealthFirst13%
American Health Packaging7%
American Regent, Inc.7%
Amneal Pharmaceuticals NY LLC7%
Breckenridge Pharmaceutical, Inc.7%
Other makers47%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How Widely Methylergonovine Is Used (Medicaid Data)

How many Methylergonovine prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

5,549
Medicaid prescriptions filled (Q1–Q4 2025)
$366,742 paid by Medicaid, before rebates

How commonly is Methylergonovine prescribed? Of the 1,682 medications we measure, Methylergonovine ranks #1,058 by Medicaid prescriptions — more than 37% of them.

Where Methylergonovine ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Methylergonovine product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

The 0.2 mg oral tablet is the most-dispensed Methylergonovine product — about 71% of these Medicaid prescriptions.

methylergonovine maleate 0.2 MG Oral Tablet Most dispensed

3,922 Medicaid prescriptions (Q1–Q4 2025) 71% of Methylergonovine prescriptions shown $275,779 paid by Medicaid, before rebates ≈ $70 per prescription, before rebates

7 of 34 listed NDCs had Medicaid claims. RxNorm 996824

1 ML methylergonovine maleate 0.2 MG/ML Injection

1,627 Medicaid prescriptions (Q1–Q4 2025) 29% of Methylergonovine prescriptions shown $90,963 paid by Medicaid, before rebates ≈ $56 per prescription, before rebates

3 of 10 listed NDCs had Medicaid claims. RxNorm 996828

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 10 of the 44 listed Methylergonovine NDCs had Medicaid claims.

Compare Methylergonovine Products

A representative set of FDA-listed product records for Methylergonovine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 15 of 15 products — FDA National Drug Code Directory. See every product, package size and price: browse all 15 Methylergonovine NDCs →

Methylergonovine Side Effects Reported to the FDA (FAERS)

After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Methylergonovine — a signal of what to watch for, not proof the drug caused it.

The effects most often named in FDA reports that mention Methylergonovine are wrong drug administered, drug exposure during pregnancy, vomiting; about 90% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.

669
Reports mentioning it
90%
Reported as serious
12
Distinct effects shown
Most reported effects
Wrong Drug Administered
69
Drug Exposure During Pregnancy
51
Vomiting
46
Dyspnoea
38
Headache
38
Abdominal Pain
35
Nausea
35
Haemorrhage
30
Cyanosis
26
Dizziness
26
Age groups
Adult · 32Infant · 5Neonate · 4Elderly · 3

Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Methylergonovine in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.

Methylergonovine FDA Approval History

How Methylergonovine went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.

Methylergonovine was first approved by the FDA in 1946 (Brand: METHERGINE · Edison Theraps Llc); the first generic version was approved in 2008. It remains available in U.S. pharmacies today.

1946
Brand approved
Brand: METHERGINE · Edison Theraps Llc
2008
First generic approved
Lower-cost ANDA competition begins
2026
Available today
Active in U.S. pharmacies

Source: Drugs@FDA.

Methylergonovine Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list 2 Methylergonovine recalls since July 2021. One of them is still ongoing and is listed first. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.

Ongoing Class II Jun 16, 2026 · The Harvard Drug Group LLC
Subpotent Drug
  • Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (2 x 10), Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, in 46268, NDC 0904-7282-10. Blister… Lots: Lots: N02327, expires: 09/2026; N02740, expires: 12/2026; N03069, expires: 08/2027. FDA record D-0609-2026 →
Class II Mar 25, 2024 · Completed · Amneal Pharmaceuticals of New York, LLC
Failed Dissolution Specifications
  • Methylergonovine Maleate Tablets, USP, 0.2mg, 12-count bottle, Rx Only, Distributed by: Amneal Pharmaceuticals, LLC, Bridgewater, NJ 08807, NDC # 69238-1605-2. Lots: Lot #: BJ01922A, exp. date 03/2024 FDA record D-0477-2024 →

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Methylergonovine in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.

Dose forms
2
Strengths
3
Forms in current FDA listings
2 of 2
In current FDA listings No current FDA listing
Ingredient (IN) Methylergonovine RxCUI 6883
  1. Dose form (SCDF) Injection RxCUI 1740921
    In current FDA listings
    Its strength (SCD)
  2. Dose form (SCDF) Oral Tablet RxCUI 372859
    In current FDA listings
    Its 2 strengths (SCD)
    • 0.125 mg RxCUI 248629
    • 0.2 mg maleate RxCUI 996824

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

What Methylergonovine Costs Pharmacies (NADAC Benchmark)

What pharmacies pay to buy Methylergonovine: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.

No national price was found for Methylergonovine injections, so the prices below are for the tablets only.

How the Pharmacy Price Has Changed

Pick a strength to see how its price has changed since Nov 2023.

Strength

For the generic 0.2 mg tablet, pharmacies paid an average of $5.70 per tablet as of Nov 18, 2026, up 26% from $4.52 a year earlier.

What pharmacies pay now
$5.70
per tablet, as of Nov 18, 2026
Last 4 weeks
Up 12%
from $5.07 on Oct 21, 2026
Last 12 months
Up 26%
from $4.52 on Nov 19, 2025
Lowest and highest since Nov 2023
$4.35 to $14.57
per tablet

Each step is one weekly survey. Arrow keys on the chart move week by week.
See the numbers, month by month
Generic 0.2 mg tablet: the average pharmacy price per tablet, the last survey of each month
MonthPharmacy price
Nov 2026$5.70
Oct 2026$5.07
Sep 2026$4.50
Aug 2026$4.35
Jul 2026$4.43
Jun 2026$5.01
May 2026$5.51
Apr 2026$5.75
Mar 2026$5.66
Feb 2026$5.30
Jan 2026$4.93
Dec 2025$4.53
Nov 2025$4.52
Oct 2025$5.04
Sep 2025$5.53
Aug 2025$5.97
Jul 2025$6.27
Jun 2025$6.37
May 2025$6.30
Apr 2025$6.52
Mar 2025$6.99
Feb 2025$7.49
Jan 2025$7.83
Dec 2024$7.89
Nov 2024$8.45
Oct 2024$7.65
Sep 2024$6.45
Aug 2024$5.99
Jul 2024$5.68
Jun 2024$5.98
May 2024$6.17
Apr 2024$6.25
Mar 2024$7.69
Feb 2024$7.69
Jan 2024$11.79
Dec 2023$14.57
Nov 2023$14.57
FormStrengthVersion What pharmacies pay
Tablet · Oral 0.2 mg Generic $5.70 per tablet NDC details & price history
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.

Methylergonovine Brand Names

Methylergonovine has 2 brand names on record: Methergine and Methylergometrine. Methergine is in the FDA’s product directory today; Methylergometrine is not. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Methergine the first brand, 1946 Methylergometrine not listed today

Who Makes Methylergonovine: Manufacturers and Labelers

13 companies list Methylergonovine products with the FDA. By number of product records, the largest are Bryant Ranch Prepack, HF Acquisition Co LLC, DBA HealthFirst, American Health Packaging. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Bryant Ranch Prepack 2 HF Acquisition Co LLC, DBA HealthFirst 2 American Health Packaging 1 American Regent, Inc. 1 Amneal Pharmaceuticals NY LLC 1 Breckenridge Pharmaceutical, Inc. 1 Granules Pharmaceuticals Inc. 1 Lupin Pharmaceuticals,Inc. 1 Major Pharmaceuticals 1 Pharmacist Pharmaceutical, LLC 1 Rising Pharma Holdings, Inc. 1 Teva Pharmaceuticals USA, Inc. 1 Volley Pharmaceuticals, LLC 1

Sources for This Methylergonovine Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Oct 8, 2026, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Methylergonovine.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 10 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
10
Finished products in the current FDA directory
15
Companies listing them (makers, repackagers, distributors)
13
FDA labeler codes behind them ⓘ
14
Linked representative label ⓘ
Granules Pharmaceuticals Inc.
Linked label effective
Oct 8, 2026
Composite sections available
19
Linked SPL Set ID
b49b1e4c-de20-446d-b80a-75c7f0d41ddf
Linked SPL Document ID
5d4f1d8a-c944-db1b-e063-6394a90a68fb
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Granules Pharmaceuticals Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →